Current treatment landscape of HR+/HER2− advanced breast cancer in the Nordics: a modified Delphi studyJürgen Geisler, Sophie Yammeni, Barbro Holm et al.|Acta Oncologica|2023Cited by 6
Abstract P5-02-20: Correlative and longitudinal transcriptomic profiling predicts patient outcomes and the efficacy of neoadjuvant HER2-targeted treatments in the randomized PREDIX HER2 trialKang Wang, Theodoros Foukakis, Yajing Zhu et al.|Cancer Research|2023Cited by 0